Please assess the completion status of the following clinical trial:

Trial Title: Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* candidate of elective PCI~* treatment with aspirin at least 5 days before PCI~Exclusion Criteria:~* high CKMB and troponin I level~* cardiac bypass in recent 3 months~* platelet count \< 70×10 9/L~* sever chronic renal failure~* active bleeding~* treatment with glycoprotein IIb/IIIa inhibitors during PCI~* treatment with bivalirudin during PCI~* sensitivity to aspirin and clopidogrel

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- omega 3 (Type: ACTIVE_COMPARATOR): receive omega 3 in addition to standard treatment
- control (Type: NO_INTERVENTION): This group is without omega 3 : just receives standard treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).